Markets Close Week as Jobs Contraction Stifles Optimism The S&P 500 (SPY $672.44 ▼ 0.14%) ended the week down 0.09%, as an unexpected loss of 92,000 jobs in February forced a defensive repositioning. While the labor data initially rattled investors, the market remains bifurcated between macro-level geopolitical anxiety in the Middle East and idiosyncratic strength in the AI-infrastructure sector.
Corporate news remains a mixed bag heading into the weekend. The FDA has granted approval for BMY’s Sotyktu for psoriatic arthritis, providing a rare fundamental win. Conversely, internal selling has dominated the news for Delek US DK, with three key executives divesting a total of $6.34 million in shares. Meanwhile, deal-making continues on the global stage, evidenced by the new critical minerals pact between Canada and Australia.
